The expression level of HSD17B12 correlated with the severity of ovarian cancer, and its expression mimicked COX-2 expression, indicating its role in increased arachidonic acid and PGE2 production during ovarian cancer progression (Kemiläinen et al. 2018). Here, HSD17B12 is linked to ovarian cancer.